Rasio Therapeutics, Inc., is a Maryland-based biopharmaceutical company that develops novel medicines using a cutting edge-computer aided drug design technology. Rasio has partnered with SilcsBio, a leader in computational drug discovery, to develop small molecules for exciting but previously inaccessible disease targets. Rasio is initially focusing on oncology and has raised seed funding to design and develop several oncology therapeutics for areas of significant unmet medical need.
Looking for a particular Rasio Therapeutics, Inc. employee's phone or email?
Rasio Therapeutics, Inc. is based in Baltimore, Maryland.
The NAICS codes for Rasio Therapeutics, Inc. are [54171, 54, 541714, 541, 5417].
The SIC codes for Rasio Therapeutics, Inc. are [87, 873].